• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

    3/12/24 1:08:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $CL alert in real time by email

    IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

    ZO Skin Health

    "Justin brings incredible experience fueling the growth of iconic personal care brands and successfully introducing innovative new products to market. His experience and commitment to serving patients with clinically efficacious regimens will be immensely valuable in driving continued growth at ZO® Skin Health," said Board Chair Todd Hirsch. "We are grateful to Mark for his many contributions to the company over the years and look forward to continue working together in his role as a member of the Board."

    Mr. Skala joins ZO® Skin Health from Standard Industries, a global leader in building solutions, solar technology and chemical products, where he served as Executive Chair of Standard Building Solutions and CEO of BMI Group. Previously, he served in various executive leadership roles at Colgate-Palmolive, Inc., where he led global strategy and growth for the company's vast portfolio of oral, personal, skin care, home care and pet nutrition products. Mr. Skala also sits on the board of Yum! Brands.

    "ZO® Skin Health is a pioneer in ensuring patients receive not only the most efficacious products, but also get maximal results from them by fostering the relationship between providers and their patients. I've long admired Dr. Obagi's vision for redefining the concept of skincare and could not be more excited to join this incredible team," said Mr. Skala. "I'm energized by the opportunity to continue expanding our product line and deepening our relationships with our network of physicians and their patients."

    "I am immensely proud of what we have built at ZO® Skin Health over the years and am grateful for such a wonderful partnership with our visionary founder Dr. Zein Obagi and the exceptional leadership team," said Mr. Williams.

    Founded in 2007 by world-renowned dermatologist Dr. Zein Obagi, the company continues to support its mission of providing healthy skin for all, regardless of age, ethnicity, unique skin condition or skin type, while utilizing the power of science to help pave the way for breakthroughs in skincare.

    "I have spent my entire life dedicated to helping patients have healthy skin through. Every year hundreds of thousands of patients benefit from our products and protocols – with their high-quality ingredients, tested formulas, exclusive medical protocols, and trusted recommendations," said Dr. Zein Obagi. "I look forward to working with Justin on the continued growth of ZO® Skin Health throughout the global medical community."

    About ZO® Skin Health

    ZO® Skin Health develops and delivers innovative skincare solutions that optimize skin health based on the latest advances in skin therapy technologies, unique delivery systems, bioengineered complexes and exclusive formulations. By providing comprehensive skincare programs for physicians and their patients, ZO® bridges the gap between therapeutic treatments and daily care, allowing patients to experience continuously healthy skin regardless of their age, ethnicity or unique skin condition. For more information, please visit www.zoskinhealth.com.

    Contact

    Jacqueline Porter

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zo-skin-health-appoints-industry-veteran-justin-skala-as-ceo-to-continue-strong-growth-302087042.html

    SOURCE ZO Skin Health

    Get the next $CL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CL

    DatePrice TargetRatingAnalyst
    10/28/2024$105.00 → $101.00Buy → Hold
    Stifel
    9/24/2024$121.00Overweight
    Piper Sandler
    9/16/2024$100.00Equal Weight → Underweight
    Wells Fargo
    9/9/2024$107.00 → $109.00Buy → Hold
    Deutsche Bank
    7/26/2024Buy → Hold
    HSBC Securities
    7/24/2024$103.00 → $95.00Buy → Hold
    Jefferies
    7/23/2024$110.00Buy
    TD Cowen
    6/24/2024$109.00Outperform
    Exane BNP Paribas
    More analyst ratings

    $CL
    SEC Filings

    View All

    SEC Form 10-Q filed by Colgate-Palmolive Company

    10-Q - COLGATE PALMOLIVE CO (0000021665) (Filer)

    8/1/25 8:32:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits

    8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    8/1/25 8:00:52 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 11-K filed by Colgate-Palmolive Company

    11-K - COLGATE PALMOLIVE CO (0000021665) (Filer)

    6/25/25 4:13:13 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Colgate-Palmolive Company Announces 2nd Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92 GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1% Net cash provided by operations was $1,484 million for the first six months of 2025 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.4% year to date The Company upd

    8/1/25 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * C

    7/21/25 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate Declares Regular Quarterly Dividend

    The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders of record on July 18, 2025. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed St

    6/12/25 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Norrington Lorrie M was granted 292 shares, increasing direct ownership by 0.76% to 38,513 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    7/2/25 4:14:02 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Newman Brian was granted 208 shares, increasing direct ownership by 5% to 4,830 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    7/2/25 4:14:01 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Bilbrey John P was granted 264 shares, increasing direct ownership by 0.74% to 36,156 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    7/2/25 4:12:54 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Colgate-Palmolive downgraded by Stifel with a new price target

    Stifel downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $101.00 from $105.00 previously

    10/28/24 7:38:39 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Piper Sandler initiated coverage on Colgate-Palmolive with a new price target

    Piper Sandler initiated coverage of Colgate-Palmolive with a rating of Overweight and set a new price target of $121.00

    9/24/24 7:35:59 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Colgate-Palmolive from Equal Weight to Underweight and set a new price target of $100.00

    9/16/24 7:25:35 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Leadership Updates

    Live Leadership Updates

    View All

    Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

    The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi

    2/10/25 6:30:00 AM ET
    $CL
    $HSIC
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical Specialities
    Health Care

    ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth

    IRVINE, Calif., March 12, 2024 /PRNewswire/ -- ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE:CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.

    3/12/24 1:08:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company Appoints Lorrie Norrington as Lead Independent Director of the Board

    Colgate-Palmolive Company (NYSE:CL) today announced that its Board of Directors has appointed Lorrie Norrington as Lead Independent Director, effective March 1, 2023. Ms. Norrington will succeed Stephen I. Sadove, the Company's current Lead Independent Director. Mr. Sadove will remain on the Audit and Personnel and Organization Committees of the Colgate Board of Directors. Ms. Norrington joined the Company's Board in September 2015 and currently serves as Chair of the Nominating, Governance and Corporate Responsibility Committee. She brings extensive global corporate leadership, digital, e-commerce and ESG experience to this role, including her experience in several senior management roles

    1/3/23 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/13/24 5:02:36 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/23 11:15:26 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/9/22 3:43:30 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    Financials

    Live finance-specific insights

    View All

    Colgate-Palmolive Company Announces 2nd Quarter 2025 Results

      Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92 GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1% Net cash provided by operations was $1,484 million for the first six months of 2025 The Company's leadership in toothpaste continued with its global market share at 41.1% year to date The Company's leadership in manual toothbrushes continued with its global market share at 32.4% year to date The Company upd

    8/1/25 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-presentations. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * C

    7/21/25 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate Declares Regular Quarterly Dividend

    The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders of record on July 18, 2025. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed St

    6/12/25 4:30:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary